Clinical trial
Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for…
NCT00004256 · Royal Marsden NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00004256 |
|---|---|
| Title | Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer |
| Official title | Randomised Phase II Study of GM-CSF to Reduce Severity of Mucositis Caused by Accelerated Radiotherapy of Laryngeal Cancer |
| Lead sponsor | Royal Marsden NHS Foundation Trust, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Oral Complications, Radiation Toxicity |
| Intervention type | Biological, Procedure, Radiation |
| Interventions | sargramostim, quality-of-life assessment, radiation therapy |
| Start date | Oct 1, 1997 |
| Completion | Jul 1, 2006 |
| First posted | Aug 25, 2003 |
| Last update posted | Nov 6, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: